🇺🇸 FDA
Patent

US 11117865

Inhibitors of bromodomain-containing protein 4 (BRD4)

granted A61KA61K9/14A61P

Quick answer

US patent 11117865 (Inhibitors of bromodomain-containing protein 4 (BRD4)) held by The Board of Regents of the University of Texas System expires Mon Sep 09 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Sep 14 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 09 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K9/14, A61P, A61P29/00, A61P37/00